Regeneron Pharmaceuticals (REGN)

$385.94 0.37 (0.10%)

17:49 EST REGN Stock Quote Delayed 15 Minutes

Volume:

Previous Close $385.94

Market Cap 40.89B

PE Ratio 31.28

EPS 12.34

Volume (Avg. Vol.) 862,700

Day's Range 382.53 - 386.60

52-Week Range 271.37 - 442.00

Dividend & Yield N/A (N/A)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

From InvestorPlace
From the Web

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Dec 17, 2019

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

By Chris Lau, InvestorPlace Contributor Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

3 Big Stock Charts for Thursday: Kraft Heinz, Wabtec, and Regeneron Pharmaceuticals

By Vince Martin, InvestorPlace Contributor Nov 7, 2019

Thursday's big stock charts detail the hopes for 3 stocks trying to recover from multi-year lows.

Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat

By William White, InvestorPlace Writer Nov 5, 2019

Regeneron Pharmaceuticals (REGN) earnings for the biotechnology company's third quarter of 2019 have REGN stock soaring on Tuesday.

Why This Just Might Be the Biggest Week for CARA Stock

By Chris Lau, InvestorPlace Contributor Nov 5, 2019

Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.

3 Undervalued Stocks to Buy According to Goldman Sachs

By Chris Tyler, InvestorPlace Contributor Oct 14, 2019

Of the undervalued stocks that Goldman Sachs recently thrust into the spotlight, these three are the most promising stocks to buy. Here's what you need to know about each.

Compare Brokers

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor Sep 27, 2019

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector

By Louis Navellier, Editor, Growth Investor Sep 14, 2019

When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).

8 Biotech Stocks to Watch After the Q2 Earnings Season

By Chris Lau, InvestorPlace Contributor Aug 20, 2019

Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist Jul 26, 2019

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

Nasdaq Today: Biotech Wrecked; Buy Microsoft?

By Bret Kenwell, InvestorPlace Contributor Jul 11, 2019

Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.

Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?

By Bret Kenwell, InvestorPlace Contributor Jun 26, 2019

Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.

Compare Brokers

5 Growthy Biotech Stocks to Buy Despite the Scrutiny

By Chris Lau, InvestorPlace Contributor May 13, 2019

Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?

Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss

By William White, InvestorPlace Writer May 7, 2019

Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period.

5 Biotech Stocks for a Long-Lived Portfolio

By Chris Lau, InvestorPlace Contributor Apr 30, 2019

Biotech stocks fell sharply in the last few weeks, mostly on no new news. This drop may have created an entry point for investors.

7 Companies With Unacceptable CEO-Worker Wage Gaps

By Will Ashworth, InvestorPlace Contributor Apr 24, 2019

While some companies are doing a good job closing their CEO-Worker wage gaps, these seven companies are not.

This Is Why You Shouldn’t Count Regeneron Stock Out

By Dana Blankenhorn, InvestorPlace Contributor Apr 22, 2019

When drug companies fall out of favor, as now, I look first to companies with a method for drug discovery like Regeneron stock.

7 Best Stocks to Buy Until the Next Seismic Shift

By Dana Blankenhorn, InvestorPlace Contributor Jan 23, 2019

No company can guarantee its future, but here are some that are well-positioned to take advantage of current trends.

Compare Brokers

3 of the Top Big Pharma Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor Jan 15, 2019

Big pharma stocks are getting good coverage from JPMorgan's healthcare event. Here are three undervalued pharmaceutical stocks to buy now.

Market Leadership’s Odd Couple: Wingstop and Regeneron

By Chris Tyler, InvestorPlace Contributor Jan 9, 2019

It might seem like an odd pairing, but WING and REGN stock have similar leadership qualities off and on the price chart.

Noteworthy Friday Option Activity: SO, LH, REGN

From Market News Video Jan 17, 2020

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Southern Company (SO), where a total volume of 26,230 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 60.9% of SO's average daily trading volume over the past month, of 4.3 million shares..

Navellier Ratings

Total Grade

Sell

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Breaking news

Regeneron Pharmaceuticals (REGN)

Navellier Ratings

Total Grade

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Breaking news

Regeneron Pharmaceuticals (REGN)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

Navellier Ratings

Total Grade

Subscriber Sign in